ArticleBMC geriatrics2026
A case report of potentially inappropriate medication-induced lead encephalopathy mimicking autoimmune encephalitis.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLead encephalopathy is an uncommon but potentially fatal condition that can present with nonspecific neurological symptoms. In older adults, it rarely mimics autoimmune diseases, leading to misdiagnosis. This case underscores the need to recognize hidden sources of lead exposure, particularly the prolonged use of herbal medicines, which is prevalent in South Asia, and to critically assess potentially inappropriate medications in geriatric care. CASE PRESENTATION: An 80-year-old male with a history of benign prostatic hyperplasia presented with subacute cognitive decline, bradykinesia, tremor, and a focal impaired consciousness seizure with right-sided motor manifestations. Cerebrospinal fluid analysis showed lymphocytic pleocytosis and elevated protein, though autoimmune and paraneoplastic panels were negative. FDG-PET revealed basal ganglia hypermetabolism with cortical hypometabolism, raising suspicion for autoimmune encephalitis. The patient showed no improvement with corticosteroid pulse therapy. On further evaluation, a history of chronic use of Ayurvedic preparations was elicited. Blood toxicology revealed elevated lead levels, confirming lead encephalopathy. He was treated with oral dimercaptosuccinic acid (DMSA), resulting in marked neurological improvement. During the two-year follow-up, the patient remained functionally independent.
conclusionsThis case demonstrates how lead encephalopathy can closely mimic autoimmune neurological conditions in older adults, potentially delaying accurate diagnosis and treatment. It reinforces the critical role of detailed history-taking, especially regarding alternative medicine use. The patient's recovery with chelation therapy highlights the reversibility of symptoms when lead toxicity is promptly identified and managed, underscoring the need for caution with unregulated therapies in geriatric care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.